{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:50:54Z","timestamp":1793274654523,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["mucosalimmunology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mucosal Immunology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1038\/s41385-021-00432-4","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T04:03:56Z","timestamp":1627877036000},"page":"1323-1334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["mTOR signaling mediates ILC3-driven immunopathology"],"prefix":"10.1016","volume":"14","author":[{"given":"Claudia","family":"Teufel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edit","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annick","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caner","family":"Ercan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Piscuoglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael N.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4453-5958","authenticated-orcid":false,"given":"Daniela","family":"Finke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank M.","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41385-021-00432-4_bib1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nri3365","article-title":"Innate lymphoid cells-a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1038\/s41385-021-00432-4_bib2","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1126\/science.288.5475.2369","article-title":"Requirement for RORgamma in thymocyte survival and lymphoid organ development","volume":"288","author":"Sun","year":"2000","journal-title":"Science"},{"key":"10.1038\/s41385-021-00432-4_bib3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ni1022","article-title":"An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells","volume":"5","author":"Eberl","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1038\/s41385-021-00432-4_bib4","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nature07537","article-title":"A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity","volume":"457","author":"Cella","year":"2009","journal-title":"Nature"},{"key":"10.1038\/s41385-021-00432-4_bib5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ni.1668","article-title":"Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells","volume":"10","author":"Cupedo","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1038\/s41385-021-00432-4_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20072713","article-title":"Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22","volume":"206","author":"Takatori","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1038\/s41385-021-00432-4_bib7","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.immuni.2008.11.001","article-title":"Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense","volume":"29","author":"Satoh-Takayama","year":"2008","journal-title":"Immunity"},{"key":"10.1038\/s41385-021-00432-4_bib8","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm1720","article-title":"Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens","volume":"14","author":"Zheng","year":"2008","journal-title":"Nat. Med."},{"key":"10.1038\/s41385-021-00432-4_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.immuni.2013.10.021","article-title":"Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection","volume":"40","author":"Guo","year":"2014","journal-title":"Immunity"},{"key":"10.1038\/s41385-021-00432-4_bib10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.chom.2011.06.002","article-title":"Lymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge","volume":"10","author":"Tumanov","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1038\/s41385-021-00432-4_bib11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.immuni.2012.05.028","article-title":"Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease","volume":"37","author":"Hanash","year":"2012","journal-title":"Immunity"},{"key":"10.1038\/s41385-021-00432-4_bib12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.immuni.2010.12.009","article-title":"CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut","volume":"34","author":"Sonnenberg","year":"2011","journal-title":"Immunity"},{"key":"10.1038\/s41385-021-00432-4_bib13","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/nature08949","article-title":"Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology","volume":"464","author":"Buonocore","year":"2010","journal-title":"Nature"},{"key":"10.1038\/s41385-021-00432-4_bib14","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1084\/jem.20111453","article-title":"IL-1\u03b2 mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells","volume":"209","author":"Coccia","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1038\/s41385-021-00432-4_bib15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/mi.2014.68","article-title":"Transcription factor c-Rel plays a crucial role in driving anti-CD40-mediated innate colitis","volume":"8","author":"Visekruna","year":"2015","journal-title":"Mucosal Immunol."},{"key":"10.1038\/s41385-021-00432-4_bib16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fimmu.2018.00023","article-title":"Divergent roles of interferon-\u03b3 and innate lymphoid cells in innate and adaptive immune cell-mediated intestinal inflammation","volume":"9","author":"Brasseit","year":"2018","journal-title":"Front Immunol."},{"key":"10.1038\/s41385-021-00432-4_bib17","doi-asserted-by":"crossref","first-page":"e10066","DOI":"10.7554\/eLife.10066","article-title":"ILC3 GM-CSF production and mobilisation orchestrate acute intestinal inflammation","volume":"5","author":"Pearson","year":"2016","journal-title":"Elife"},{"key":"10.1038\/s41385-021-00432-4_bib18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.immuni.2006.05.017","article-title":"Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology","volume":"25","author":"Uhlig","year":"2006","journal-title":"Immunity"},{"key":"10.1038\/s41385-021-00432-4_bib19","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1038\/s41385-021-00432-4_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrm3757","article-title":"Making new contacts: the mTOR network in metabolism and signalling crosstalk","volume":"15","author":"Shimobayashi","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1038\/s41385-021-00432-4_bib21","doi-asserted-by":"crossref","unstructured":"Di Luccia, B., Gilfillan, S., Cella, M., Colonna, M. & Huang, S. C.-C. ILC3s integrate glycolysis and mitochondrial production of reactive oxygen species to fulfill activation demands. J. Exp. Med. 216, 2231\u20132241 (2019).","DOI":"10.1084\/jem.20180549"},{"key":"10.1038\/s41385-021-00432-4_bib22","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.4049\/jimmunol.1301228","article-title":"TCF-1 controls ILC2 and NKp46+ROR\u03b3t+ innate lymphocyte differentiation and protection in intestinal inflammation","volume":"191","author":"Mielke","year":"2013","journal-title":"J. Immunol."},{"key":"10.1038\/s41385-021-00432-4_bib23","doi-asserted-by":"crossref","first-page":"10961","DOI":"10.1073\/pnas.1005641107","article-title":"Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity","volume":"107","author":"Cella","year":"2010","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1038\/s41385-021-00432-4_bib24","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.immuni.2010.10.012","article-title":"Regulation of cytokine secretion in human CD127(+) LTi-like innate lymphoid cells by Toll-like receptor 2","volume":"33","author":"Crellin","year":"2010","journal-title":"Immunity"},{"key":"10.1038\/s41385-021-00432-4_bib25","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1084\/jem.20140145","article-title":"Nfil3 is required for the development of all innate lymphoid cell subsets","volume":"211","author":"Seillet","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1038\/s41385-021-00432-4_bib26","doi-asserted-by":"crossref","unstructured":"Mikami, Y. et al. NCR+ ILC3 maintain larger STAT4 reservoir via T-BET to regulate type 1 features upon IL-23 stimulation in mice. Eur. J. Immunol. 48, 1174\u20131180 (2018).","DOI":"10.1002\/eji.201847480"},{"key":"10.1038\/s41385-021-00432-4_bib27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/mi.2013.33","article-title":"IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism","volume":"7","author":"Eken","year":"2014","journal-title":"Mucosal Immunol."},{"key":"10.1038\/s41385-021-00432-4_bib28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/ni.2797","article-title":"Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, ROR\u03b3t and dectin-2","volume":"15","author":"Taylor","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1038\/s41385-021-00432-4_bib29","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.4049\/jimmunol.1501541","article-title":"mTOR mediates IL-23 induction of neutrophil IL-17 and IL-22 production","volume":"196","author":"Chen","year":"2016","journal-title":"J. Immunol."},{"key":"10.1038\/s41385-021-00432-4_bib30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nature12526","article-title":"Type 2 innate lymphoid cells control eosinophil homeostasis","volume":"502","author":"Nussbaum","year":"2013","journal-title":"Nature"},{"key":"10.1038\/s41385-021-00432-4_bib31","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1126\/science.1122927","article-title":"Selective stimulation of T cell subsets with antibody-cytokine immune complexes","volume":"311","author":"Boyman","year":"2006","journal-title":"Science"},{"key":"10.1038\/s41385-021-00432-4_bib32","doi-asserted-by":"crossref","unstructured":"Fachi, J. L. et al. Hypoxia enhances ILC3 responses through HIF-1-\u03b1-dependent mechanism. Mucosal Immunol. 14, 828\u2013841 (2021).","DOI":"10.1038\/s41385-020-00371-6"},{"key":"10.1038\/s41385-021-00432-4_bib33","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.cell.2016.07.043","article-title":"The spectrum and regulatory landscape of intestinal innate lymphoid cells are shaped by the microbiome","volume":"166","author":"Gury-BenAri","year":"2016","journal-title":"Cell"},{"key":"10.1038\/s41385-021-00432-4_bib34","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/s41467-020-15612-2","article-title":"Microbiota-induced tissue signals regulate ILC3-mediated antigen presentation","volume":"11","author":"Lehmann","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1038\/s41385-021-00432-4_bib35","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.immuni.2010.10.017","article-title":"Regulated expression of nuclear receptor ROR\u03b3t confers distinct functional fates to NK cell receptor-expressing ROR\u03b3t(+) innate lymphocytes","volume":"33","author":"Vonarbourg","year":"2010","journal-title":"Immunity"},{"key":"10.1038\/s41385-021-00432-4_bib36","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1128\/IAI.01508-13","article-title":"Neutrophils are a source of gamma interferon during acute Salmonella enterica serovar Typhimurium colitis","volume":"82","author":"Spees","year":"2014","journal-title":"Infect. Immun."},{"key":"10.1038\/s41385-021-00432-4_bib37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/mi.2011.54","article-title":"Opposing consequences of IL-23 signaling mediated by innate and adaptive cells in chemically induced colitis in mice","volume":"5","author":"Cox","year":"2012","journal-title":"Mucosal Immunol."},{"key":"10.1038\/s41385-021-00432-4_bib38","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1164\/rccm.201410-1782OC","article-title":"Innate lymphoid cells are the predominant source of IL-17A during the early pathogenesis of acute respiratory distress syndrome","volume":"193","author":"Muir","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1038\/s41385-021-00432-4_bib39","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.immuni.2004.08.018","article-title":"Interleukin-17 family members and inflammation","volume":"21","author":"Kolls","year":"2004","journal-title":"Immunity"},{"key":"10.1038\/s41385-021-00432-4_bib40","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1038\/s41467-018-07277-9","article-title":"Crosstalks between mTORC1 and mTORC2 variagate cytokine signaling to control NK maturation and effector function","volume":"9","author":"Wang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1038\/s41385-021-00432-4_bib41","doi-asserted-by":"crossref","first-page":"e28174","DOI":"10.4161\/trla.28174","article-title":"Signaling crosstalk between the mTOR complexes","volume":"2","author":"Xie","year":"2014","journal-title":"Translation"},{"key":"10.1038\/s41385-021-00432-4_bib42","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.crohns.2014.08.014","article-title":"The use of sirolimus (rapamycin) in the management of refractory inflammatory bowel disease in children","volume":"8","author":"Mutalib","year":"2014","journal-title":"J. Crohns Colitis"},{"key":"10.1038\/s41385-021-00432-4_bib43","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1136\/gut.2008.157297","article-title":"Use of sirolimus (rapamycin) to treat refractory Crohn's disease","volume":"57","author":"Massey","year":"2008","journal-title":"Gut"},{"key":"10.1038\/s41385-021-00432-4_bib44","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0092-8674(92)90029-C","article-title":"RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement","volume":"68","author":"Shinkai","year":"1992","journal-title":"Cell"},{"key":"10.1038\/s41385-021-00432-4_bib45","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.1096472","article-title":"Thymic origin of intestinal alphabeta T cells revealed by fate mapping of RORgammat+ cells","volume":"305","author":"Eberl","year":"2004","journal-title":"Science"},{"key":"10.1038\/s41385-021-00432-4_bib46","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.cmet.2008.10.002","article-title":"Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy","volume":"8","author":"Bentzinger","year":"2008","journal-title":"Cell Metab."},{"key":"10.1038\/s41385-021-00432-4_bib47","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-213X-1-4","article-title":"Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus","volume":"1","author":"Srinivas","year":"2001","journal-title":"BMC Dev. Biol."},{"key":"10.1038\/s41385-021-00432-4_bib48","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1084\/jem.150.3.580","article-title":"Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors","volume":"150","author":"Unkeless","year":"1979","journal-title":"J. Exp. Med."}],"container-title":["Mucosal Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41385-021-00432-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41385-021-00432-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021922002264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021922002264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41385-021-00432-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:09:17Z","timestamp":1761829757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933021922002264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1933021922002264"],"URL":"https:\/\/doi.org\/10.1038\/s41385-021-00432-4","relation":{},"ISSN":["1933-0219"],"issn-type":[{"value":"1933-0219","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"mTOR signaling mediates ILC3-driven immunopathology","name":"articletitle","label":"Article Title"},{"value":"Mucosal Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41385-021-00432-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 The authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}